Offer a chlamydia test annually to all sexually active people aged under 30 years, as well as for those who identify themselves at risk.

Quick guide for best practice chlamydia case management

test bluetreat orangePID orangeretest orangePM orange 

Why test? 

Chlamydia is the most common bacterial STI in Australia. In 2017, of the 100 775 chlamydia notifications, 73% were among people aged 15-29 years.1

Who and when to test?

Australian STI Management Guidelines recommend opportunistically testing all sexually active people aged <30, as well as anyone who identifies themselves at risk annually. 

For more information about who and when to test, see STI/HIV Testing Tool (PDF). 

Opportunistic testing

Need some help bringing up opportunistic STI testing? Here are some suggestions for you*:
One liners

For more examples of offering routine STI/HIV testing, see the STI/HIV Testing Tool (PDF). 

*These opportunistic testing one-liners are from the STI/HIV Testing Tool (PDF), and GPs who participated in the MoCCA project (used here with their permission). 

Patient resources about testing

For a factsheet about chlamydia for your patient, including information about testing

Chlamydia Factsheet

For all patient resources, click below

Patient resources

GP resources about testing

For more information about testing, including step-by-step advice on offering routine STI testing in different consultations

STI/HIV Testing Tool (PDF)

For all GP resources, click below

GP resources

Key guidelines for chlamydia case management

For information about the entire chlamydia case management pathway, including specimen collection

Australian STI Management Guidelines (updated March 2018). 

For who and when to test, including in specific populations 

RACGP Red Book Guidelines for Preventive Activities in General Practice (9th Edition, updated 2018).



treat orange




1. The Kirby Institute Annual Surveillance Report 2018, available at: https://kirby.unsw.edu.au/report/hiv-viral-hepatitis-and-sexually-transmissible-infections-australia-annual-surveillance 

MoCCA is funded by the National Health and Medical Research Council (APP1150014) and is a collaboration between the University of Melbourne and our project investigators and partner organisations. Click here for a list of our collaborators.

uomlogo footer trim